MODULI CO2 / AG

Informazioni principali

  • Nome commerciale:
  • MODULI CO2 / AG
  • Utilizzare per:
  • Esseri umani
  • Tipo di medicina:
  • Dispositivo medico

Documenti

  • per il pubblico:
  • Il foglio illustrativo per questo prodotto non è al momento disponibile, é possibile inviare una richiesta al nostro Servizio Clienti ed essere avvisati nel momento in cui è disponibile sulla nostra piattaforma.


    Richiedi il foglio illustrativo per il pubblico.

  • per i professionisti:
  • Il foglio illustrativo per questo prodotto non è al momento disponibile, é possibile inviare una richiesta al nostro Servizio Clienti ed essere avvisati nel momento in cui è disponibile sulla nostra piattaforma.


    Richiedi il foglio illustrativo per i professionisti.

Localizzazione

  • Disponibile in:
  • MODULI CO2 / AG
    Italia
  • Lingua:
  • italiano

Informazioni terapeutiche

  • Gruppo terapeutico:
  • STRUMENTAZIONE PER IL MONITORAGGIO DI PARAMETRI VITALI - COMPONENTI ACCESSORI HARDWARE

Altre informazioni

Status

  • Fonte:
  • Ministero della Salute - Italia
  • Stato dell'autorizzazione:
  • S
  • Data dell'autorizzazione:
  • 07-04-2010
  • Ultimo aggiornamento:
  • 09-08-2016
  • Il foglio illustrativo per questo prodotto non è al momento disponibile, é possibile inviare una richiesta al nostro Servizio Clienti ed essere avvisati nel momento in cui è disponibile sulla nostra piattaforma.

    Richiedi il foglio illustrativo per il pubblico.

22-1-2019

Modification of the existing maximum residue level for trifloxystrobin in broccoli

Modification of the existing maximum residue level for trifloxystrobin in broccoli

Published on: Mon, 21 Jan 2019 In accordance with Article 6 of Regulation (EC) No 396/2005, the applicant Bayer Hellas AG submitted a request to the competent national authority in Greece to modify the existing maximum residue level (MRL) for the active substance trifloxystrobin in broccoli. The data submitted in support of the request were found to be sufficient to derive an MRL proposal for broccoli. Adequate analytical methods for enforcement are available to control the residues of trifloxystrobin o...

Europe - EFSA - European Food Safety Authority EFSA Journal

4-1-2019

Modification of the existing maximum residue levels for lambda‐cyhalothrin in celeries, fennel and rice

Modification of the existing maximum residue levels for lambda‐cyhalothrin in celeries, fennel and rice

Published on: Thu, 03 Jan 2019 In accordance with Article 6 of Regulation (EC) No 396/2005, the applicant Syngenta Crop Protection AG submitted a request to the competent national authority in Greece to modify the existing maximum residue levels (MRLs) for lambda‐cyhalothrin in celeries, fennel and rice. The data submitted in support of the request were found to be sufficient to derive tentative MRL proposals for the concerned crops. They are tentative as formally the general data gap identified in the ...

Europe - EFSA - European Food Safety Authority EFSA Journal

10-10-2018

Minister Bruins tekent Green Deal voor duurzame zorg

Minister Bruins tekent Green Deal voor duurzame zorg

Minister Bruno Bruins voor Medische Zorg en Sport heeft vandaag de Green Deal ‘Duurzame zorg voor een gezonde toekomst’ getekend. Hiermee maken 132 partijen uit de zorg, overheid en bedrijfsleven afspraken om de zorg in Nederland duurzamer te maken. Inzet is het terugdringen van CO2-uitstoot, zuiniger gebruik van grondstoffen, minder medicijnresten in het water en een gezonde leefomgeving voor patiënt, cliënt en zorgmedewerkers.

Netherlands - Ministerie van Volksgezondheid, Welzijn en Sport

21-9-2018

Modification of the existing maximum residue level for clothianidin in potatoes

Modification of the existing maximum residue level for clothianidin in potatoes

Published on: Thu, 20 Sep 2018 00:00:00 +0200 In accordance with Article 6 of Regulation (EC) No 396/2005, the applicant Bayer CropScience AG submitted a request to the competent national authority in Germany to modify the existing maximum residue level (MRL) for the active substance clothianidin to accommodate the use on potatoes imported from Canada. The data submitted in support of the request were found to be sufficient to derive a MRL proposal. Adequate analytical methods for enforcement are availa...

Europe - EFSA - European Food Safety Authority Publications

2-12-2018

As a science-based agency we rely on evidence generated from data to inform regulatory decisions. #FDA's #SundayTweetorial discusses how we use data from real-world settings to enhance what we know about medical products. This week we'll announce policies

As a science-based agency we rely on evidence generated from data to inform regulatory decisions. #FDA's #SundayTweetorial discusses how we use data from real-world settings to enhance what we know about medical products. This week we'll announce policies

As a science-based agency we rely on evidence generated from data to inform regulatory decisions. #FDA's #SundayTweetorial discusses how we use data from real-world settings to enhance what we know about medical products. This week we'll announce policies to advance these efforts pic.twitter.com/2co2Hz4jUt

FDA - U.S. Food and Drug Administration

26-11-2018

Jivi (Bayer AG)

Jivi (Bayer AG)

Jivi (Active substance: damoctocog alfa pegol) - Centralised - Authorisation - Commission Decision (2018)7987 of Mon, 26 Nov 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/004054/0000

Europe -DG Health and Food Safety

21-11-2018

EU/3/18/2098 (Bayer AG)

EU/3/18/2098 (Bayer AG)

EU/3/18/2098 (Active substance: Larotrectinib) - Orphan designation - Commission Decision (2018)7808 of Wed, 21 Nov 2018 European Medicines Agency (EMA) procedure number: EMA/OD/117/18

Europe -DG Health and Food Safety

21-11-2018

EU/3/18/2097 (Bayer AG)

EU/3/18/2097 (Bayer AG)

EU/3/18/2097 (Active substance: Larotrectinib) - Orphan designation - Commission Decision (2018)7807 of Wed, 21 Nov 2018 European Medicines Agency (EMA) procedure number: EMA/OD/116/18

Europe -DG Health and Food Safety

21-11-2018

EU/3/18/2084 (Bayer AG)

EU/3/18/2084 (Bayer AG)

EU/3/18/2084 (Active substance: Anetumab ravtansine) - Orphan designation - Commission Decision (2018)7793 of Wed, 21 Nov 2018 European Medicines Agency (EMA) procedure number: EMA/OD/258/17

Europe -DG Health and Food Safety

10-9-2018

Silapo (STADA Arzneimittel AG)

Silapo (STADA Arzneimittel AG)

Silapo (Active substance: epoetin zeta) - Centralised - Yearly update - Commission Decision (2018)5944 of Mon, 10 Sep 2018

Europe -DG Health and Food Safety

4-9-2018

Epoetin alfa Hexal (Hexal AG)

Epoetin alfa Hexal (Hexal AG)

Epoetin alfa Hexal (Active substance: epoetin alfa) - Centralised - 2-Monthly update - Commission Decision (2018)5857 of Tue, 04 Sep 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/726/II/WS/1406

Europe -DG Health and Food Safety

29-8-2018

Filgrastim Hexal (Hexal AG)

Filgrastim Hexal (Hexal AG)

Filgrastim Hexal (Active substance: Filgrastim) - Centralised - Yearly update - Commission Decision (2018)5766 of Wed, 29 Aug 2018

Europe -DG Health and Food Safety

28-8-2018

EU/3/18/2064 (Bayer AG)

EU/3/18/2064 (Bayer AG)

EU/3/18/2064 (Active substance: Copanlisib) - Orphan designation - Commission Decision (2018)5734 of Tue, 28 Aug 2018 European Medicines Agency (EMA) procedure number: EMA/OD/071/18

Europe -DG Health and Food Safety

23-8-2018

EU/3/18/1979 (Bayer AG)

EU/3/18/1979 (Bayer AG)

EU/3/18/1979 (Active substance: Human monoclonal IgG2 antibody against tissue factor pathway inhibitor) - Corrigendum - Commission Decision (2018)1246 of Thu, 23 Aug 2018

Europe -DG Health and Food Safety

1-8-2018

Eylea (Bayer AG)

Eylea (Bayer AG)

Eylea (Active substance: aflibercept) - Centralised - 2-Monthly update - Commission Decision (2018)5222 of Wed, 01 Aug 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2392/II/45

Europe -DG Health and Food Safety

11-7-2018

Betaferon (Bayer AG)

Betaferon (Bayer AG)

Betaferon (Active substance: Interferon beta-1b) - Centralised - Yearly update - Commission Decision (2018)4527 of Wed, 11 Jul 2018

Europe -DG Health and Food Safety

10-7-2018

Temozolomide HEXAL (Hexal AG)

Temozolomide HEXAL (Hexal AG)

Temozolomide HEXAL (Active substance: temozolomide) - Centralised - Yearly update - Commission Decision (2018) 4481 of Tue, 10 Jul 2018

Europe -DG Health and Food Safety

27-6-2018

EU/3/18/1995 (Bayer AG)

EU/3/18/1995 (Bayer AG)

EU/3/18/1995 (Active substance: Larotrectinib) - Transfer of orphan designation - Commission Decision (2018)4092 of Wed, 27 Jun 2018 European Medicines Agency (EMA) procedure number: EMA/OD/213/17/T/01

Europe -DG Health and Food Safety

27-6-2018

EU/3/15/1606 (Bayer AG)

EU/3/15/1606 (Bayer AG)

EU/3/15/1606 (Active substance: (S)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide hydrogen sulfate) - Transfer of orphan designation - Commission Decision (2018)4094 of Wed, 27 Jun 2018 European Medicines Agency (EMA) procedure number: EMA/OD/184/15/T/02

Europe -DG Health and Food Safety

25-6-2018

Xofigo (Bayer AG)

Xofigo (Bayer AG)

Xofigo (Active substance: Radium Ra 223 dichloride) - Centralised - Renewal - Commission Decision (2018)4018 of Mon, 25 Jun 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2653/R/30

Europe -DG Health and Food Safety

24-5-2018

Stivarga (Bayer AG)

Stivarga (Bayer AG)

Stivarga (Active substance: regorafenib) - Centralised - Renewal - Commission Decision (2018)3266 of Thu, 24 May 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2573/R/25

Europe -DG Health and Food Safety

24-5-2018

Xarelto (Bayer AG)

Xarelto (Bayer AG)

Xarelto (Active substance: rivaroxaban) - Centralised - Renewal - Commission Decision (2018)3264 of Thu, 24 May 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/944/R/60

Europe -DG Health and Food Safety